HX 531
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H531959

CAS#: 188844-34-0

Description: HX 531 is an antagonist of retinoid X receptors.

Chemical Structure

img
HX 531
CAS# 188844-34-0
Instruction

Theoretical Analysis

Hodoodo Cat#: H531959
Name: HX 531
CAS#: 188844-34-0
Chemical Formula: C29H29N3O4
Exact Mass: 483.22
Molecular Weight: 483.570
Elemental Analysis: C, 72.03; H, 6.05; N, 8.69; O, 13.23

Price and Availability

Size Price Availability Quantity
5mg USD 250 2 Weeks
10mg USD 450
25mg USD 800 2 Weeks
Bulk inquiry

Synonym: HX 531; HX-531; HX531.

IUPAC/Chemical Name: 4-(5,7,7,10,10-pentamethyl-2-nitro-8,9-dihydronaphtho[2,3-b][1,5]benzodiazepin-12-yl)benzoic acid

InChi Key: SXKPGYKPQPYJER-UHFFFAOYSA-N

InChi Code: InChI=1S/C29H29N3O4/c1-28(2)12-13-29(3,4)22-16-25-20(15-21(22)28)26(17-6-8-18(9-7-17)27(33)34)30-23-14-19(32(35)36)10-11-24(23)31(25)5/h6-11,14-16H,12-13H2,1-5H3,(H,33,34)

SMILES Code: O=C(O)C1=CC=C(C2=NC3=CC([N+]([O-])=O)=CC=C3N(C)C4=CC5=C(C(C)(C)CCC5(C)C)C=C42)C=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 483.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kilbourne AM, Goodrich DE, Lai Z, Almirall D, Nord KM, Bowersox NW, Abraham KM. Reengaging veterans with serious mental illness into care: preliminary results from a national randomized trial. Psychiatr Serv. 2015 Jan 1;66(1):90-3. doi: 10.1176/appi.ps.201300497. PubMed PMID: 25554233; PubMed Central PMCID: PMC4640185.

2: Bradley SM, Chan PS, Spertus JA, Kennedy KF, Douglas PS, Patel MR, Anderson HV, Ting HH, Rumsfeld JS, Nallamothu BK. Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR. Circ Cardiovasc Qual Outcomes. 2012 May;5(3):290-7. doi: 10.1161/CIRCOUTCOMES.112.966044. PubMed PMID: 22576845; PubMed Central PMCID: PMC3520092.

3: Tsujita E, Yamashita Y, Takeishi K, Matsuyama A, Tsutsui S, Matsuda H, Toshima T, Taketomi A, Shirabe K, Ishida T, Maehara Y. Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era. Am Surg. 2012 Apr;78(4):419-25. PubMed PMID: 22472398.

4: Waitzfelder B, Pihoker C, Klingensmith G, Case D, Anderson A, Bell RA, Lawrence JM, Mayer-Davis EJ, Imperatore G, Standiford D, Rodriguez BL, Dabelea D, Seid M; SEARCH for Diabetes in Youth Study Group.. Adherence to guidelines for youths with diabetes mellitus. Pediatrics. 2011 Sep;128(3):531-8. doi: 10.1542/peds.2010-3641. PubMed PMID: 21859914; PubMed Central PMCID: PMC3164090.

5: Casares S, López-Mayorga O, Vega MC, Cámara-Artigas A, Conejero-Lara F. Cooperative propagation of local stability changes from low-stability and high-stability regions in a SH3 domain. Proteins. 2007 May 15;67(3):531-47. PubMed PMID: 17330285.

6: Dai X, Sayama K, Shirakata Y, Hanakawa Y, Yamasaki K, Tokumaru S, Yang L, Wang X, Hirakawa S, Tohyama M, Yamauchi T, Takashi K, Kagechika H, Hashimoto K. STAT5a/PPARgamma pathway regulates involucrin expression in keratinocyte differentiation. J Invest Dermatol. 2007 Jul;127(7):1728-35. PubMed PMID: 17330131.

7: Muñoz JI, Costas E, Rodríguez-Calvo MS, Suárez-Peñaranda JM, López-Rivadulla M, Concheiro L. A high-performance liquid chromatography method for hypoxanthine determination in vitreous humour: application to estimation of post mortem interval. Hum Exp Toxicol. 2006 May;25(5):279-81. PubMed PMID: 16758771.